European Commission sues AstraZeneca over COVID-19 jab supplies
April 27, 2021Manufacturing and Production AstraZeneca, AstraZeneca vaccine, COVID-19, EU, European Commission, covid 19 news, covid-19 news, european union, pharma, pharma news
The European Commission (EC) announced yesterday that it was suing AstraZeneca for failing to respect its contract to supply COVID-19 …
NICE updates guidelines on atrial fibrillation based on new evidence
April 27, 2021Manufacturing and Production NICE
NICE has updated its guideline on the diagnosis and management of atrial fibrillation (AF) based on new evidence found since …
Hilco Industrial acquires all machinery and equipment from Legacy Pharmaceutical Switzerland
April 27, 2021Manufacturing and Production
Hilco Industrial Acquisitions, an Amsterdam based industrial asset disposition and acquisition company, has acquired all machinery and equipment from the …
Data published on novel molecules for leukaemia treatment
April 27, 2021Manufacturing and Production oncology
STORM Therapeutics have published new data in Nature on targeting RNA modifying enzymes for the development of new anti-cancer therapeutics, …
Home breast cancer treatment offered in UK for first time
April 27, 2021Manufacturing and Production
Phesgo, a treatment for breast cancer, will now be offered to patients at home in the UK for the very …
Study finds superior outcomes for fracture risk reduction in osteoporosis
April 26, 2021Sales and Marketing
A real-world evidence study, presented at the International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders, has shown for the first …
Dermavant Sciences announce data of two Phase III trials for psoriasis
April 26, 2021Sales and Marketing
Dermavant Sciences have presented successful data from two Phase III trials for tapinarof, for the treatment of psoriasis in adults, …
LEO Pharma receives positive CHMP opinion for dermatitis treatment
April 26, 2021Sales and Marketing CHMP, EMA, EU, dermatitis
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion …
Sanofi’s RSV drug sees Phase III clinical trial success
April 26, 2021Sales and Marketing AstraZeneca, Sanofi
Sanofi have announced positive topline results from the Phase III MELODY trial into nirsevimab, which demonstrated protection against respiratory syncytial …
Phoenix Cardiac gains CE Mark for “game-changer” MR device
April 26, 2021Sales and Marketing CE Mark, EU, cardiovascular
Phoenix Cardiac Devices have received CE Mark certification for its BACE (basal annuloplasty of the cardia externally) device, a novel …
Phamafile.com’s top 10 news stories of the week
April 23, 2021Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma, pharma news
Among our top 10 stories this week: A study has found the Pfizer COVID-19 vaccine to have a significantly reduced …
Researchers find possible new treatment for several cancers
April 23, 2021Medical Communications Cancer, The Institute of Cancer Research, cancer treatment, kidney cancer treatment, pharma, pharma news
Researchers at The Institute of Cancer Research (ICR) in London have discovered a new use for an ovarian and breast …
Lonza to invest over £150 million on new molecule complex
April 23, 2021Medical Communications Lonza
Lonza have announced the construction of a new small molecule manufacturing complex at its Visp site in Switzerland, which will …
MHRA gives green light to new cardiovascular treatment
April 23, 2021Medical Communications MHRA, cardiovascular
The MHRA has granted a Great Britain Marketing Authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce the risk …
AstraZeneca drug evaluated in nine eosinophilic diseases
April 23, 2021Medical Communications AstraZeneca
AstraZeneca announced on Thursday that the first patients had been dosed in the Phase III Fasenra (benralizumab) clinical trial in …
Lipidor to begin Phase III trial on psoriasis treatment
April 22, 2021Phase III trials, lipidor, pharma, pharma news, psoriasis
Lipidor has submitted an application with the Indian Medical Products Agency to begin a Phase III trial on their drug …
Novo Nordisk to expand obesity study into oral treatment
April 22, 2021Novo Nordisk, obesity
Novo Nordisk is planning to initiate a Phase IIIa study of oral semaglutide in obesity, expanding on its Phase IIIa …
Jubilant’s oral remdesivir formulation shows positive results in human trial
April 22, 2021COVID-19, Gilead, Jubilant Pharma, covid-19 treatment, pharma, pharma news, remdesivir
Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an …
UK Company launches COVID-19 neutralisation assay development kit
April 22, 2021COVID-19
The Native Antigen Company, a supplier of reagents for research into diagnostics and vaccines, have announced the launch of its …
Bharat Biotech jab shows 100% efficacy against severe COVID-19
April 22, 2021COVID-19, India
Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
